Geron Corp.
NASDAQ:GERN 2:17:46 PM EDT
| Market Cap (Intraday) | 2.55B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.29 |
| 50-Day MA | $4.46 |
| 200-Day MA | $3.61 |
Geron Corp. Stock, NASDAQ:GERN
919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404
United States of America
Phone: +1.650.473.7700
Number of Employees: 141
Description
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.